NO942653L - Fremgangsmåte for å anslå det biologiske potensialet til en valgt carsinoma hos en pasient - Google Patents
Fremgangsmåte for å anslå det biologiske potensialet til en valgt carsinoma hos en pasientInfo
- Publication number
- NO942653L NO942653L NO942653A NO942653A NO942653L NO 942653 L NO942653 L NO 942653L NO 942653 A NO942653 A NO 942653A NO 942653 A NO942653 A NO 942653A NO 942653 L NO942653 L NO 942653L
- Authority
- NO
- Norway
- Prior art keywords
- estimating
- carcinoma
- patient
- biopsy
- potential
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/5014—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing toxicity
- G01N33/5017—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing toxicity for testing neoplastic activity
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57407—Specifically defined cancers
- G01N33/57434—Specifically defined cancers of prostate
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S436/00—Chemistry: analytical and immunological testing
- Y10S436/811—Test for named disease, body condition or organ function
- Y10S436/813—Cancer
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Biomedical Technology (AREA)
- Chemical & Material Sciences (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Molecular Biology (AREA)
- Medicinal Chemistry (AREA)
- Analytical Chemistry (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Pathology (AREA)
- Toxicology (AREA)
- Food Science & Technology (AREA)
- General Physics & Mathematics (AREA)
- Physics & Mathematics (AREA)
- Cell Biology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Tropical Medicine & Parasitology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Hospice & Palliative Care (AREA)
- Oncology (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Investigating Or Analyzing Materials By The Use Of Electric Means (AREA)
- Magnetic Resonance Imaging Apparatus (AREA)
- Measurement And Recording Of Electrical Phenomena And Electrical Characteristics Of The Living Body (AREA)
Abstract
En fremgangsmåte for å bedømme det biologiske potensialet til prostatacarcinom i en pasient er kjennetegnet ved at man først oppnår en vevsprøve av prostatacarcinomet hos en pasient og deretter kvantifiserer vaskulariteten i denne vevsprøven, og ut fra resultatene bedømmer det biologiske potensialet på prostatacarcinomet. Det tilveiebringes også en fremgangsmåte for å bedømme det biologiske potensialet for et utvalgt carci- nora i en pasient, hvilken fremgangsmåte innbefatter at man først oppnår en biopsiprøve fra et carcinom ved hjelp av en metode valgt fra gruppen bestående av nålebiopsi, endoskop*i, laproskopi og cystoskopi og deretter kvantifiserer biopsi- prøvens vaskularitet, og ut fra resultatene bedømmer det biologiske potensialet til det valgte carcinom.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US82112092A | 1992-01-15 | 1992-01-15 | |
PCT/US1993/000449 WO1993014407A1 (en) | 1992-01-15 | 1993-01-15 | A method for estimating the biologic potential of a selected carcinoma in a patient |
Publications (2)
Publication Number | Publication Date |
---|---|
NO942653D0 NO942653D0 (no) | 1994-07-14 |
NO942653L true NO942653L (no) | 1994-09-12 |
Family
ID=25232578
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO942653A NO942653L (no) | 1992-01-15 | 1994-07-14 | Fremgangsmåte for å anslå det biologiske potensialet til en valgt carsinoma hos en pasient |
Country Status (11)
Country | Link |
---|---|
US (2) | US5688694A (no) |
EP (1) | EP0643839B1 (no) |
JP (1) | JPH07503069A (no) |
AT (1) | ATE145728T1 (no) |
AU (1) | AU673153B2 (no) |
CA (1) | CA2128031A1 (no) |
DE (1) | DE69306250T2 (no) |
ES (1) | ES2095038T3 (no) |
FI (1) | FI943355A (no) |
NO (1) | NO942653L (no) |
WO (1) | WO1993014407A1 (no) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1595948A3 (en) * | 1999-03-05 | 2006-03-01 | Mitsubishi Rayon Co., Ltd. | Carriers having biological substance |
JP2003520830A (ja) * | 2000-01-25 | 2003-07-08 | エドワーズ ライフサイエンシーズ コーポレイション | 再狭窄および吻合内膜過形成処置のための送達系 |
CA2428062A1 (en) | 2000-11-06 | 2002-05-10 | Board Of Regents, The University Of Texas System | Laser scanning cytometry mediated analysis of therapeutic efficacy in tumors |
US6993175B2 (en) * | 2001-09-07 | 2006-01-31 | Quest Diagnostics Investments Incorporated | Methods for measuring microvascular density in tumors |
US7229423B2 (en) * | 2003-02-05 | 2007-06-12 | Timi 3 System, Inc | Systems and methods for applying audible acoustic energy to increase tissue perfusion and/or vasodilation |
US20070100335A1 (en) * | 2005-10-28 | 2007-05-03 | Apple Medical Corporation | Instrument for electrosurgical excision procedure for the uterine cervix |
US8321010B2 (en) * | 2009-09-04 | 2012-11-27 | Konstantin Georgievich Korotkov | Method for determining the condition of a biological object and device for making same |
FR2964744B1 (fr) * | 2010-09-10 | 2015-04-03 | Univ Versailles St Quentin En Yvelines | Test pronostic de l'evolution d'une tumeur solide par analyse d'images |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0553273A4 (en) * | 1990-10-16 | 1998-04-22 | Biomed Frontiers Inc | Polymer-deferoxamine-ferric iron adducts for use in magnetic resonance imaging |
-
1993
- 1993-01-15 CA CA002128031A patent/CA2128031A1/en not_active Abandoned
- 1993-01-15 JP JP5512702A patent/JPH07503069A/ja active Pending
- 1993-01-15 ES ES93903564T patent/ES2095038T3/es not_active Expired - Lifetime
- 1993-01-15 AT AT93903564T patent/ATE145728T1/de not_active IP Right Cessation
- 1993-01-15 WO PCT/US1993/000449 patent/WO1993014407A1/en active IP Right Grant
- 1993-01-15 DE DE69306250T patent/DE69306250T2/de not_active Expired - Fee Related
- 1993-01-15 EP EP93903564A patent/EP0643839B1/en not_active Expired - Lifetime
- 1993-01-15 AU AU34782/93A patent/AU673153B2/en not_active Ceased
-
1994
- 1994-07-14 NO NO942653A patent/NO942653L/no unknown
- 1994-07-14 FI FI943355A patent/FI943355A/fi not_active Application Discontinuation
- 1994-12-07 US US08/351,724 patent/US5688694A/en not_active Expired - Fee Related
-
1995
- 1995-06-05 US US08/462,791 patent/US5616469A/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
AU3478293A (en) | 1993-08-03 |
DE69306250D1 (de) | 1997-01-09 |
WO1993014407A1 (en) | 1993-07-22 |
FI943355A0 (fi) | 1994-07-14 |
CA2128031A1 (en) | 1993-07-22 |
NO942653D0 (no) | 1994-07-14 |
AU673153B2 (en) | 1996-10-31 |
EP0643839A1 (en) | 1995-03-22 |
DE69306250T2 (de) | 1997-03-20 |
EP0643839B1 (en) | 1996-11-27 |
ATE145728T1 (de) | 1996-12-15 |
FI943355A (fi) | 1994-09-14 |
ES2095038T3 (es) | 1997-02-01 |
US5616469A (en) | 1997-04-01 |
JPH07503069A (ja) | 1995-03-30 |
US5688694A (en) | 1997-11-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Paulson et al. | Predictors of lymphatic spread in prostatic adenocarcinoma: uro-oncology research group study | |
ITTO20010411A0 (it) | Metodo e dispositivo per l'esecuzione di test e saggi ad alta processivita' ed alto valore biologico su cellule e/o composti. | |
DE69906992D1 (de) | Zweite medizinische indikation einer partikelverabreichungsmethode | |
EP1035215A3 (en) | Method and probe set for detecting cancer | |
EP1743939A3 (en) | Method for isolation of RNA from formalin-fixed paraffin-embedded tissue specimens | |
NO964187L (no) | Fremgangsmåte for fremstilling av mykobakterier | |
ATE223051T1 (de) | Verfahren zur diagnose gutartiger prostataerkrankungen | |
NO942653D0 (no) | Fremgangsmåte for å anslå det biologiske potensialet til en valgt carsinoma hos en pasient | |
BG97041A (bg) | Проби на база протеин-нуклеинова киселина и метод за използването им при имуноизследване | |
EP0684471A3 (en) | Total organic carbon meter | |
EP1127536A3 (en) | Biochip | |
Bauer et al. | Dissociative experiences and psychopathological symptomatology in a Scottish sample. | |
DE50105971D1 (de) | Verfahren zur Diagnose von Sepsis unter Bestimmung von CA 125 | |
FR2810114B1 (fr) | Methode, procede, test immunologique et kit de diagnostic d'un adenocarcinome de la prostate ou d'une hypertrophie benigne de la prostate | |
EP1191346A3 (en) | Tracking of the spin resonance frequency in magnetic resonance | |
NO980965D0 (no) | En fremgangsmåte for å fastslå oksygenkonsentrasjonen i en pröve | |
CA2100464A1 (en) | Prescreening of prostate cancer by serum prostatic specific antigen | |
EP0832689A3 (en) | Specimen collection kit | |
WO1998021365A3 (en) | Method for detection of metastatic prostate cancer | |
EP1039394A3 (en) | Method and apparatus for analyzing data | |
ES8707798A1 (es) | Un procedimiento para analizar una muestra de tejido para determinar la presencia de antigeno de la hepatitis no a no b | |
PT1218749E (pt) | Sistema de deteccao de cancro da prostata atraves da analise do psa/igf-l livre | |
ITBO980569A0 (it) | Strumento ad ago per l' esecuzione di biopsie . | |
WO1993002217A3 (fr) | Sondes oligonucleotidiques pour le typage et la detection des papillomavirus humains | |
Felmingham | Sensitivity Testing and Mic Determination of Obligate Anaerobes |